| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |